Guanghua Co., Ltd. announced that the company plans to use 20 million yuan of its own capital to pledge investment from the Wuxi Qingsong Qianpan Venture Capital Partnership, with a pledge ratio of 57.13%. The total size of the fund is 3.51 million yuan. Qingsong Capital is the general partner and executive partner. It plans to invest in a medical device company in Zhejiang that specializes in high-performance orthopedic implants. As a limited partner, the company does not participate in the daily operation of the fund and has no control or significant influence on the fund, and the partnership is not included in the scope of consolidated statements. This investment is still in the preparation and fundraising stage. The fund industry association filing needs to be completed, and there is uncertainty about the implementation progress.

Guanghua Co., Ltd. announced that the company plans to use 20 million yuan of its own capital to pledge investment from the Wuxi Qingsong Qianpan Venture Capital Partnership, with a pledge ratio of 57.13%. The total size of the fund is 3.51 million yuan. Qingsong Capital is the general partner and executive partner. It plans to invest in a medical device company in Zhejiang that specializes in high-performance orthopedic implants. As a limited partner, the company does not participate in the daily operation of the fund and has no control or significant influence on the fund, and the partnership is not included in the scope of consolidated statements. This investment is still in the preparation and fundraising stage. The fund industry association filing needs to be completed, and there is uncertainty about the implementation progress.